Not applicableLooking for participantsNCT05792033What this trial is testingMulticentric Prospective T1 Urinary Bladder Cancer RegistryWho this might be right forT1 Urinary Bladder Cancer Medical University of Vienna 700
Testing effectiveness (Phase 2)Study completedNCT00981656What this trial is testingRadiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder CancerWho this might be right forBladder Cancer Radiation Therapy Oncology Group 37
Testing effectiveness (Phase 2)Looking for participantsNCT03945162What this trial is testingIntravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") PatientsWho this might be right forNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT06770582What this trial is testingTesting the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialWho this might be right forNon-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v8 National Cancer Institute (NCI) 160
Not applicableStudy completedNCT01180478What this trial is testingComparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/CancerWho this might be right forBladder Cancer Clinical Research Office of the Endourological Society 965
Not applicableStudy completedNCT01750970What this trial is testingEndoscopic Resection of Bladder TumorsWho this might be right forBladder Tumor Hopital Foch 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03504163What this trial is testingPembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]Who this might be right forBladder Cancer Memorial Sloan Kettering Cancer Center 45
Post-approval studies (Phase 4)WithdrawnNCT06390111What this trial is testingA Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.Who this might be right forBladder CancerTa/T1CIS Ferring Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT04452591What this trial is testingStudy of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-GuerinWho this might be right forNon Muscle Invasive Bladder CancerHigh-grade Ta/ T1 Papillary Disease Bladder Cancer CG Oncology, Inc. 190
Large-scale testing (Phase 3)Study completedNCT01920269What this trial is testingIntravesical Adjuvant Electromotive Mitomycin-CWho this might be right forBladder Cancer TNM Staging Primary Tumor (T) TaBladder Cancer TNM Staging Primary Tumor (T) T1Bladder Cancer Transitional Cell Grade University of Rome Tor Vergata 331
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793What this trial is testingToripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 StudyWho this might be right forUrinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more First Affiliated Hospital of Wenzhou Medical University 106
Very early researchEnded earlyNCT03266900What this trial is testingA Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free SurvivalWho this might be right forBladder CancerBladder Urothelial Carcinoma University Health Network, Toronto 2
Large-scale testing (Phase 3)UnknownNCT00003725What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerWho this might be right forBladder Cancer Anthra Pharmaceuticals 300
Not applicableLooking for participantsNCT06026332What this trial is testingADSTILADRIN Early Utilization and Outcomes in the Real World SettingWho this might be right forBladder Cancer Ferring Pharmaceuticals 400
Large-scale testing (Phase 3)Study completedNCT00002990What this trial is testingSurgery and BCG in Treating Patients With Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 1,288
Not applicableUnknownNCT05167916What this trial is testingCan Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Replace Repeat Biopsy?Who this might be right forBladder Cancer Mansoura University 200
Early research (Phase 1)Study completedNCT03258593What this trial is testingDurvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)Who this might be right forUrinary Bladder Neoplasms National Cancer Institute (NCI) 15
Early research (Phase 1)WithdrawnNCT04109092What this trial is testingStimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102Who this might be right forUrinary Bladder Neoplasms Eisai Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07322263What this trial is testingIntravesical GEM/DOCE for HR BCG-Unresponsive NMIBCWho this might be right forBladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more Michael A. O'Donnell 174
Large-scale testing (Phase 3)Ended earlyNCT00042887What this trial is testingChemotherapy With or Without Surgery in Treating Patients With Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 58